Can Synthetic Vaccines Change The World’s Approach To Infectious Disease Crises?

 
• By Lucie Ellis-Taitt

Emerging Company Profile: Emergex Vaccines will use its nanobody technology to develop entirely synthetic immunizations against the world’s most concerning infectious diseases, including Ebola; evolving current options for vaccine stockpiling and national repositories.

Emerging Company Profile Regular column feature image Version 2
Emergex Vaccines to bring new approach for synthetic immunizations into the clinic

More from Start-Ups & SMEs

More from Business